Journal of Urologic Oncology

Search

Page Path

Kidney Cancer

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study: Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):59-67. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600660033
Cited By 1; Full text PubReader ePub PDF

Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis: Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, Myung Ha Kim, Jae Hung Jung, Mi Ah Han, Seung Hwan Lee, In Gab Jeong, Sun Il Kim, Eu Chang Hwang; Journal of Urologic Oncology. 2024;22(1):34-41. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600140007
Cited By 2; Full text PubReader ePub PDF Supplementary Material

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

5,199	Complex Epidemiology of Prostate Cancer in Asian Countries
3,582	Current Update on Prostate Cancer Immunotherapy
3,251	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
3,175	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
3,049	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023

Cited By 10	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 7	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac